The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease

Neurogenetics

Volumn 7, Issue 1, 2006, Pages 27-30

  Metzger, Silke ^a   Bauer, Peter ^a   Tomiuk, Juergen ^a   Laccone, Franco ^b   Didonato, Stefano ^c   Gellera, Cinzia ^c   Soliveri, Paola ^c   Lange, Herwig W ^d   Weirich Schwaiger, Helga ^e   Wenning, Gregor K ^e   Melegh, Bela ^f   Havasi, Victoria ^f   Balikó, Lazlo ^f,g   Wieczorek, Stefan ^h   Arning, Larissa ^h   Zaremba, Jacek ⁱ   Sulek, Anna ⁱ   Hoffman Zacharska, Dorota ⁱ   Basak, A Nazli ^j   Ersoy, Nagehan ^j   Zidovska, Jana ^k   Kebrdlova, Vera ^l   Pandolfo, Massimo ^m   Ribaï, Pascale ^m   Kadasi, Ludovit ⁿ   Kvasnicova, Marta ^o   Weber, Bernhard H F ^o   Kreuz, Friedmar ^p   Dose, Matthias ⁿ   Stuhrmann, Manfred ^q   Riess, Olaf ^a   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d Air Rehazentrum   (Germany)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY OF PÉCS   (Hungary)

^g Csolnoky Ferenc County Hospital   (Hungary)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^j BOGAZICI UNIVERSITY   (Turkey)

^k CHARLES UNIVERSITY   (Czech Republic)

^l ERASME HOSPITAL   (Belgium)

^m INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

ⁿ Department of Clinical Genetics ^*  (Germany)

^o UNIVERSITY OF REGENSBURG   (Germany)

^p KLINIKUM CHEMNITZ   (Germany)

^q LEIBNIZ UNIVERSITY HANNOVER   (Germany)

more..

Author keywords

Age at onset; Genetic modifiers; Huntington's disease; S18Y polymorphism; Ubiquitin carboxy terminal hydrolase L1 (UCHL1)

Indexed keywords

HUNTINGTIN; POLYGLUTAMINE; UBIQUITIN HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CHILD; CHROMOSOME 4P; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GENE; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; HUNTINGTON CHOREA; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; ONSET AGE; PATHOGENESIS; PATIENT; PRIORITY JOURNAL;

AGE OF ONSET; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; TRINUCLEOTIDE REPEATS; UBIQUITIN THIOLESTERASE;

EID: 33644658207     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-005-0023-z     Document Type: Article

References (11)

1. Haigh B, Huq M, Hayden MR. Huntington disease. In: Gene-Reviews (online). Available at:http://www.geneclinics.org/servlet/access?id=8888891&key= 28UhX7Ix0tj-L&gry=&fcn=y&fw=uoW9&filename=/profiles/huntington/ index.html. Cited May 25, 2004
2. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA (1993) Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet 2:1547-1549
3. Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR (1997) The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 60:1202-1210
4. Nazé P, Vuillaume I, Destée A, Pasquier F, Sablonnière B (2002) Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neurosci Lett 328:1-4
5. Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Krüger R, Hattori N, Mellick GD, Quattrone A, Satoh J, Toda T, Wang J, Ioannidis JP, de Andrade M, Rocca WA, the UCHL1 Global Genetics Consortium (2004) UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 55:512-521
6. Maraganore DM, Farrer MJ, Hardy JA, Lincoln SJ, McDonnell SK, Rocca WA (1999) Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 53:1858-1860
7. Wintermeyer P, Krüger R, Kuhn W, Müller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schöls L, Epplen JT, Riess O (2000) Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport 14:2079-2082
8. Li J-L, Hayden MR, Almqvist EW, Brinkman RR, Durr A, Dodé C, Morrison PJ, Sochowersky O, Ross CA, Margolis RL, Rosenblatt A, Gómez-Tortosa E, Cabrero DM, Novelletto A, Frontali M, Nance M, Trent RJA, McCusker E, Jones R, Paulsen JS, Harrison M, Zanko A, Abramson RA, Russ AL, Knowlton B, Djoussé L, Mysore JS, Tariot S, Gusella MF, Wheeler VC, Atwood LD, Cupples LA, Saint-Hilaire M, Cha J-HJ, Hersch SM, Koroshetz WJ, Gusella JF, MacDonald ME, Myers RH (2003) A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study. Am J Hum Genet 73:682-687
9. Djoussé L, Knowlton B, Hayden MR, Almqvist EW, Brinkman RR, Ross CA, Margolis RL, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJA, McCusker E, Gómez-Tortosa E, Cabrero DM, Jones R, Zanko A, Nance M, Abramson RA, Suchowersky O, Paulsen JS, Harrison MB, Yang Q, Cupples LA, Mysore J, Gusella JF, MacDonald ME, Myers RH (2004) Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics 5:109-114
10. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect á-synuclein degradation and Parkinson's disease susceptibility. Cell 111:209-218
11. Spillantini MG, Goedert M (2000) The á-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann NY Acad Sci 920:16-27